News Focus
News Focus
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: alternatepatel post# 17681

Friday, 09/29/2017 9:24:08 AM

Friday, September 29, 2017 9:24:08 AM

Post# of 20689

...Amgen didn't try to circumvent Humira formulation patents.

The question is whether AMGN didn't try... or whether AMGN simply didn't know how to do it in a manner that preserved biosimilarity. I lean toward the later interpretation.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”